Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study

Autor: Fahad W Ahmed, Sherin Bakhashab, Inda T Bastaman, Jolanta U. Weaver, Rachel E Crossland, Michael Glanville

Publikováno v: International Journal of Molecular Sciences, Vol 19, Iss 10, p 3242 (2018)
International Journal of Molecular Sciences
Volume 19
Issue 10

Type 1 diabetes (T1DM) is associated with increased cardiovascular disease (CVD) and reduced life expectancy. We thus hypothesized that anti-angiogenic miRs are increased in T1DM, and the cardioprotective effect of metformin is mediated via reducing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48ad2e10dd024a84519be0ec0dbe6e19
http://www.mdpi.com/1422-0067/19/10/3242